Inflammatory pathway spurs cancer stem cells to resist HER2-targeted breast cancer treatment
Thursday, July 19, 2012 - 17:00
in Health & Medicine
Researchers have discovered one reason why the cancer cells become resistant to Herceptin: They turn on a completely different pathway, one that is involved in inflammation, fueling the cancer independently of HER2.